Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML)
remains a life-threatening malignancy in children, with current survival rates of ∼ 70%. …

Diagnosis, treatment, response monitoring, and outcome of pediatric acute myeloid leukemia
(AML) have made enormous progress during the past decades. Because AML is a rare …

The intricate time-dependent structure and the non thermal processes in the solar atmosphere
indicate the importance of magnetic fields in turbulent cosmical bodies. We are now …

Chromosomal rearrangements of the human MLL/KMT2A gene are associated with infant,
pediatric, adult and therapy-induced acute leukemias. Here we present the data obtained …

The preliminary results of the Einstein Observatory stellar X-ray survey are presented. To
date, 143 soft X-ray sources have been identified with stellar counterparts, leaving no doubt …

Chromosomal rearrangements of the human MLL (mixed lineage leukemia) gene are
associated with high-risk infant, pediatric, adult and therapy-induced acute leukemias. We used …

It is pointed out that the cool main-sequence components of cataclysmic binaries and low-mass
X-ray binaries will undergo rotational braking by a magnetically coupled stellar wind, in a …

Translocations involving chromosome 11q23 frequently occur in pediatric acute myeloid
leukemia (AML) and are associated with poor prognosis. In most cases, the MLL gene is …

Although imatinib, a BCR-ABL tyrosine kinase inhibitor, is used to treat acute Philadelphia
chromosome–positive (Ph + ) leukemia, it does not prevent central nervous system (CNS) …

Purpose Blinatumomab is a bispecific T-cell engager antibody construct targeting CD19 on
B-cell lymphoblasts. We evaluated the safety, pharmacokinetics, recommended dosage, and …